M. Benavent
Services Hospital
5 Papers
9 Citations
M. Benavent is an academic researcher from Services Hospital. The author has contributed to research in topics: Axitinib & Neuroendocrine tumors. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
A phase II/III randomized double-blind study of octreotide acetate LAR with axitinib versus octreotide acetate LAR with placebo in patients with advanced G1-G2 NETs of non-pancreatic origin (AXINET trial-GETNE-1107).
Rocio Garcia-Carbonero,M. Benavent,Paula Jiménez Fonseca,Daniel Castellano,Teresa Alonso,Alex Teulé,Ana Custodio,Salvatore Tafuto,Adelaida La Casta Munoa,Francesca Spada,Carlos López-López,Toni Ibrahim,Maria Jose Villanueva Silva,Vega Iranzo,Pilar García-Alfonso,Encarnación González,Enrique Grande,Guillermo Crespo,Jaume Capdevila +18 more
TL;DR: Axitinib is a potent and selective VEGFR-1,2,3 inhibitor, with proven activity against several vascular-depen...
32
SUNitinib with EVOfosfamide (TH-302) for G1/G2 metastatic pancreatic neuroendocrine tumours (pNETs) naïve for systemic treatment. The SUNEVO phase II trial of the Spanish task force group for neuroendocrine and endocrine tumours (GETNE)
Enrique Grande,C. López,T. Alonso Gordoa,M. Benavent,Jaume Capdevila,Alexandre Teule,Ana Custodio,Isabel Sevilla,Pablo Gajate,Javier Molina-Cerrillo,J. Hernando Cubero,Rocio Garcia-Carbonero +11 more
TL;DR: SUN + EVO is active in pts with advanced pNETs, but the toxicity profile of the combination negatively affects tolerability, which may limit the number of patients likely to benefit from this therapy.
4
429OA phase II trial of palbociclib in metastatic grade 1/2 pancreatic neuroendocrine tumors: The PALBONET study on behalf of the Spanish Taskforce Group of Neuroendocrine Tumors (GETNE)
E. Grande Pulido,Alexandre Teule,T. Alonso-Gordoa,P. Jiménez-Fonseca,M. Benavent,Jaume Capdevila,Ana Custodio,R. Vera,Javier Munarriz,A. La Casta-Muñoa,Rocio Garcia-Carbonero +10 more
4
1159MO Survival and prognostic factors analysis of 535 grade 3 gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN): Data from the Spanish Taskforce of Neuroendocrine Tumours Registry (R-GETNE)
P. Jimenez Fonseca,A. La Salvia,Jaume Capdevila,A Castaño,M. Benavent,Vicente Alonso-Orduña,Teresa Alonso,M. Sánchez Cánovas,Ana Custodio,R. Garcia Centeno,Marta Llanos,Gustavo Crespo,A. Lopez de Sa,Alexandre Teule,L. Oliva Fernandez,I. Torres,J. Gallego Plazas,Carles Pericay,C. Villabona,C. López +19 more
1
1174P RESUNET (GETNE-2016-01): A phase II study to evaluate the efficacy and safety of the rechallenge with sunitinib in G1/G2 pancreatic neuroendocrine tumours (pNET). A Spanish Task Force Group in neuroendocrine and endocrine tumours (GETNE) study
Enrique Grande,P. Espinosa-Olarte,R. Serrano,Pilar Jiménez,Teresa Alonso,M. Benavent,J. Capdevila Castillón,Adelaida Lacasta,R. Yaya Tur,Agustín Carmona,I. Gallegos,Robinson Rodríguez,A.O. Castillo Trujillo,J. Molina Cerrillo,J. Hernando,A. Bujedo Martinez,Rocio Garcia-Carbonero +16 more
1